T cell engineering for adoptive T cell therapy: safety and receptor avidity

Overview of attention for article published in Cancer Immunology, Immunotherapy, September 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 16,968 followers.

T cell engineering for adoptive T cell therapy: safety and receptor avidity https://t.co/3glOgcq2Yn https://t.co/KWfB9JLq0J

T cell engineering for adoptive T cell therapy: safety and receptor avidity. https://t.co/sPvT2qaoj1

RT @celltherapynews: T cell engineering for adoptive T cell therapy: safety and receptor avidity. @TU_Muenchen https://t.co/SqV8IgQ0Jf

RT @celltherapynews: T cell engineering for adoptive T cell therapy: safety and receptor avidity. @TU_Muenchen https://t.co/SqV8IgQ0Jf

T cell engineering for adoptive T cell therapy: safety and receptor avidity. @TU_Muenchen https://t.co/SqV8IgQ0Jf

T cell engineering for adoptive T cell therapy: safety and receptor avidity https://t.co/I0eECxHpaT

T cell engineering for adoptive T cell therapy: safety and receptor avidity. https://t.co/XLY6d61QRj

T cell engineering for adoptive T cell therapy: safety and receptor avidity https://t.co/MQeAXkIHmm